Beta Drugs Ltd vs Jubilant Pharmova Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1771 as of 12 Jun 15:30 . The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 yearsThe P/E Ratio of Jubilant Pharmova Ltd changed from 13 on March 2021 to 16.8 on March 2025 . This represents a CAGR of 5.26% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 115.37 crore on March 2021 to ₹ 1923 crore on March 2025 . This represents a CAGR of 75.55% over 5 yearsThe Market Cap of Jubilant Pharmova Ltd changed from ₹ 10838 crore on March 2021 to ₹ 14220 crore on March 2025 . This represents a CAGR of 5.58% over 5 years The revenue of Beta Drugs Ltd for the Mar '26 is ₹ 96.86 crore as compare to the Dec '25 revenue of ₹ 89.58 crore. This represent the growth of 8.13% The revenue of Jubilant Pharmova Ltd for the Mar '26 is ₹ 2313 crore as compare to the Dec '25 revenue of ₹ 2143 crore. This represent the growth of 7.97% The ebitda of Beta Drugs Ltd for the Mar '26 is ₹ 20.57 crore as compare to the Dec '25 ebitda of ₹ 19.3 crore. This represent the growth of 6.58% The ebitda of Jubilant Pharmova Ltd for the Mar '26 is ₹ 349.3 crore as compare to the Dec '25 ebitda of ₹ 270.2 crore. This represent the growth of 29.27% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 9.05 crore over 6 quarters. This represents a CAGR of 0.74% The net profit of Jubilant Pharmova Ltd changed from ₹ 481.8 crore to ₹ 119.3 crore over 8 quarters. This represents a CAGR of -50.24% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jubilant Pharmova Ltd changed from 37.14 % on March 2021 to 414.06 % on March 2025 . This represents a CAGR of 61.97% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Jubilant Pharmova Ltd

Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978.
Company name was changed to 'Jubliant Organosys Limited' in November, 2001 and was again changed to 'Jubilant Life Sciences Limited' in October, 2009 and further it attained a new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.

FAQs for the comparison of Beta Drugs Ltd and Jubilant Pharmova Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Jubilant Pharmova Ltd?

Market cap of Beta Drugs Ltd is 1,795 Cr while Market cap of Jubilant Pharmova Ltd is 15,536 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Jubilant Pharmova Ltd?

The stock performance of Beta Drugs Ltd and Jubilant Pharmova Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Jubilant Pharmova Ltd?

As of June 14, 2026, the Beta Drugs Ltd stock price is INR ₹1771.2. On the other hand, Jubilant Pharmova Ltd stock price is INR ₹975.3.

How do dividend payouts of Beta Drugs Ltd and Jubilant Pharmova Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Jubilant Pharmova Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.